s-propylcysteine has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, C; Huang, Y; Li, W; Li, X; Ma, F; Zhang, A; Zhang, L; Zhu, Y | 1 |
| Chiu, CP; Tsai, SJ; Yang, HT; Yin, MC | 1 |
2 other study(ies) available for s-propylcysteine and Disease Models, Animal
| Article | Year |
|---|---|
S-Propargyl-cysteine Exerts a Novel Protective Effect on Methionine and Choline Deficient Diet-Induced Fatty Liver via Akt/Nrf2/HO-1 Pathway.
Topics: Animals; Antioxidants; Biomarkers; Choline Deficiency; Cysteine; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Heme Oxygenase-1; Hep G2 Cells; Humans; Lipid Peroxidation; Liver; Male; Membrane Proteins; Methionine; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; RNA Interference; Signal Transduction; Transfection | 2016 |
s-Allyl cysteine, s-ethyl cysteine, and s-propyl cysteine alleviate β-amyloid, glycative, and oxidative injury in brain of mice treated by D-galactose.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cysteine; Disease Models, Animal; Galactose; Glycosylation; Humans; Male; Mice; Mice, Inbred C57BL; Oxidative Stress | 2011 |